Teladoc (TDOC) Q3 2026 Earnings Call Transcript
Teladoc (TDOC) reported Q3 2026 revenue near the upper end of guidance, with adjusted EBITDA above expectations. Integrated care and BetterHelp segments both performed well. The company introduced Teladoc 1, a new care model, and acquired Teledoc Health to expand hybrid care services. BetterHelp's insurance revenue grew to $32 million, with a run rate of over $140 million annually.
How this was made
The 30-second read
Why it matters
The earnings beat may trigger short-term buying, but longer-term performance hinges on insurance adoption and new product execution.
Market read
Fresh earnings data offers actionable insight for traders focusing on telehealth stocks.
What to watch
Potential cash-pay challenges and execution risk for Teladoc 1 rollout.
Background
Teladoc's Q3 2026 earnings call provided updated financial metrics and strategic updates.
Ticker impact
Q3 2026 earnings call disclosed revenue near the upper end of guidance and insurance revenue of $32M exceeding expectations.
likely upward pressure as market prices in better-than-expected insurance revenue.
Management highlighted strong insurance growth and EBITDA above guidance, providing fresh positive guidance.
Market effects
Telehealth sector may see renewed investor interest on insurance growth.
U.S. healthcare services stocks could benefit from Teladoc's positive outlook.
Limited to U.S. markets; no immediate global macro effect.
Counterpoint
If insurance growth stalls, the stock could face pressure despite the earnings beat.
Key entities
- CompanyTeladoc Health
Provider of virtual care services.
- ExecutiveMike Grasher
New CFO who discussed the quarter results.
